Related Experiment Video

Updated: Jul 24, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

492

Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology

Vijay Kumar1, Caitlin Bauer1, John H Stewart2

  • 1Department of Interdisciplinary Oncology, Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University Health Science Center (LSUHSC), 1700 Tulane Avenue, New Orleans, LA 70012, USA.

European Journal of Cell Biology
|July 9, 2023
PubMed

Insights

The cGAS/STING pathway, a key innate immune sensor, plays a crucial role in cancer development and metastasis. Targeting this pathway offers a promising strategy to inhibit tumor growth and spread.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Pattern-recognition receptors (PRRs) are essential for innate immunity, detecting threats via cell membrane, cytosolic, or nuclear localization.
  • The cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway is a cytosolic PRR system crucial for innate immune responses.
  • cGAS/STING activation generates type 1 interferons (IFNs) and proinflammatory cytokines, potentially preventing cancer development, growth, and metastasis.

Purpose of the Study:

  • To delineate the impact of cancer cell-specific cGAS/STING signaling pathway alterations on tumor progression.
  • To explore therapeutic strategies targeting the cGAS/STING pathway in cancer cells for enhanced treatment outcomes.

Main Methods:

  • Review of existing literature on PRRs, cGAS/STING pathway, and cancer immunology.
  • Analysis of the role of cGAS/STING in tumor growth, development, and metastasis.
  • Discussion of potential therapeutic interventions targeting the cGAS/STING pathway in oncology.

Main Results:

  • Alterations in the cGAS/STING pathway within cancer cells significantly influence tumor growth and metastatic potential.
  • Activation of cGAS/STING signaling can lead to type 1 IFN production, which may inhibit cancer progression.
  • The cGAS/STING pathway presents a potential target for novel cancer therapies.

Conclusions:

  • The cGAS/STING pathway is a critical regulator in cancer immunity and progression.
  • Targeting cancer cell-specific cGAS/STING signaling offers a promising avenue for novel anticancer therapies.
  • Combination strategies involving cGAS/STING pathway modulation and existing treatments may improve cancer management.
Keywords:
CancerInflammationNF-κBSTINGTIMETMETumorType 1 IFNscGAS

More Related Videos

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli07:26

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli

Published on: December 26, 2020

4.1K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
48.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
47.1K